This investigation, originally published by O Bastidor, raises serious questions about regulatory impartiality in Brazil's capital markets. It examines allegations of conflicts of interest surrounding a key CVM opinion in the Oncoclínicas case and why the final decision could have far-reaching consequences for investor confidence. [Go to the article]...